Skip to main navigation

Company
Pathologies
Product Candidates
Newsroom
- News
- Presentations
- Publications
- Links
Investors

Breadcrumb

Home / Investors / Press Releases /

Press Releases

Keyword Search

Year

Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo

05/14/21

Auris Medical Provides Update on Bentrio Program in Allergy

05/07/21

Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch

04/13/21

Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021

04/08/21

Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results

03/31/21

Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, 2021

03/24/21

Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis

01/29/21

Investors

Investors

Overview
Events and Presentations
Corporate Governance
SEC Filings
Press Releases
Stock Information
Investor FAQs
Investor Contact
Email Alerts

Investor Toolkit

Print Page
RSS Feeds

Careers | Contacts

Copyright © Auris Medical 2021